Medis El (Israel) links up with Institut Pasteur
This article was originally published in Clinica
Medis El (Israel) has signed an agreement with the Institut Pasteur in Paris, France, to use the company's CellScan System for AIDS research and therapy. The research programme will investigate lymphocyte activity and behaviour. CellScan uses blood samples to detect HIV, infectious and autoimmune diseases and breast, colon and lung cancer.
You may also be interested in...
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
Hikma and Sesen Bio have struck a deal that will see Hikma distribute the Vicineum brand in the MENA region.
By establishing a dedicated consumer healthcare subsidiary, Norgine is hoping it can grow its $200m-plus Movicol laxative brand and take advantage of M&A opportunities in the OTC market.